latest news in Cannabinoid Regulation
Medicare Expands Hemp Incentives but Doctors Demand Clear Clinical Proof
Washington, Saturday, 12 September 2026.
Despite Medicare offering incentives for hemp-derived treatments, doctors remain reluctant to recommend them without standardized clinical trials, highlighting a critical gap between policy and physician adoption.